Fellowship · Lubbock, TX
Sponsored by Texas Tech University Health Sciences Center at Lubbock
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial.
Nature medicine · 2021 · 192 citations · Fred Poordad
Diagnosis and Management of Acute Pancreatitis.
Diagnostics (Basel, Switzerland) · 2025 · 21 citations · Nitish Mittal
BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial.
Hepatology (Baltimore, Md.) · 2022 · 85 citations · Fred Poordad
Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events.
Journal for immunotherapy of cancer · 2024 · 30 citations · Nitish Mittal
Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH.
Liver international : official journal of the International Association for the Study of the Liver · 2024 · 21 citations · Fred Poordad
The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2021 · 44 citations ·
Anorexia nervosa and adrenal hormones: a systematic review and meta-analysis.
European journal of endocrinology · 2023 · 12 citations · Subhanudh Thavaraputta
Worse Survival and Gastrointestinal Toxicity Outcomes Among Patients Receiving Proton Pump Inhibitors During Checkpoint Inhibitor Therapy.
Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 8 citations · Nitish Mittal